Silvestris N - Search Results

1

Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?

Spagnolo CC, Pepe F, Ciappina G, Nucera F, Ruggeri P, Squeri A, Speranza D, Silvestris N, Malapelle U, Santarpia M. Spagnolo CC, et al. Among authors: silvestris n. Crit Rev Oncol Hematol. 2024 May;197:104332. doi: 10.1016/j.critrevonc.2024.104332. Epub 2024 Apr 4. Crit Rev Oncol Hematol. 2024. PMID: 38580184 Free article. Review.

2

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database.

Barbieri MA, Sorbara EE, Cicala G, Santoro V, Cutroneo PM, Franchina T, Santarpia M, Silvestris N, Spina E. Barbieri MA, et al. Among authors: silvestris n. Front Oncol. 2022 Nov 23;12:1005626. doi: 10.3389/fonc.2022.1005626. eCollection 2022. Front Oncol. 2022. PMID: 36505840 Free PMC article.

3

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario.

Spagnolo CC, Giuffrida G, Cannavò S, Franchina T, Silvestris N, Ruggeri RM, Santarpia M. Spagnolo CC, et al. Among authors: silvestris n. Cancers (Basel). 2022 Dec 30;15(1):246. doi: 10.3390/cancers15010246. Cancers (Basel). 2022. PMID: 36612243 Free PMC article. Review.

4

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Santarpia M, Ciappina G, Spagnolo CC, Squeri A, Passalacqua MI, Aguilar A, Gonzalez-Cao M, Giovannetti E, Silvestris N, Rosell R. Santarpia M, et al. Among authors: silvestris n. Transl Lung Cancer Res. 2023 Feb 28;12(2):346-368. doi: 10.21037/tlcr-22-639. Epub 2023 Feb 20. Transl Lung Cancer Res. 2023. PMID: 36895930 Free PMC article. Review.

5

Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System.

Barbieri MA, Sorbara EE, Russo G, Cicala G, Franchina T, Santarpia M, Silvestris N, Spina E. Barbieri MA, et al. Among authors: silvestris n. Cancers (Basel). 2023 Mar 20;15(6):1851. doi: 10.3390/cancers15061851. Cancers (Basel). 2023. PMID: 36980737 Free PMC article.

6

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine.

Longhitano E, Muscolino P, Lo Re C, Ferrara SA, Cernaro V, Gembillo G, Tessitore D, Speranza D, Figura F, Santarpia M, Silvestris N, Santoro D, Franchina T. Longhitano E, et al. Among authors: silvestris n. Cancers (Basel). 2023 Mar 21;15(6):1891. doi: 10.3390/cancers15061891. Cancers (Basel). 2023. PMID: 36980777 Free PMC article. Review.

7

Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.

Ruggeri RM, Spagnolo CC, Alibrandi A, Silvestris N, Cannavò S, Santarpia M. Ruggeri RM, et al. Among authors: silvestris n. J Endocrinol Invest. 2023 Nov;46(11):2399-2409. doi: 10.1007/s40618-023-02096-2. Epub 2023 Apr 20. J Endocrinol Invest. 2023. PMID: 37076759

8

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM).

Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, Sacchi P, Baldanti F, Di Maio M, Beretta GD, Cinieri S, Silvestris N. Pedrazzoli P, et al. Among authors: silvestris n. ESMO Open. 2023 Jun;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. Epub 2023 Apr 3. ESMO Open. 2023. PMID: 37104930 Free PMC article. Review.

9

Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database.

Russo G, Barbieri MA, Sorbara EE, Cicala G, Franchina T, Santarpia M, Silvestris N, Spina E. Russo G, et al. Among authors: silvestris n. Biomedicines. 2023 Aug 20;11(8):2311. doi: 10.3390/biomedicines11082311. Biomedicines. 2023. PMID: 37626807 Free PMC article.

10

Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review.

Muscolino P, Granata B, Omero F, De Pasquale C, Campana S, Calabrò A, D'Anna F, Drommi F, Pezzino G, Cavaliere R, Ferlazzo G, Silvestris N, Speranza D. Muscolino P, et al. Among authors: silvestris n. Front Oncol. 2023 Aug 25;13:1247614. doi: 10.3389/fonc.2023.1247614. eCollection 2023. Front Oncol. 2023. PMID: 37692859 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

380 results

Search Page